ERAS vs CIG Comparison

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Cia Energetica DE Minas Gerais - Cemig is a Brazilian energy company engaged in the generation, transmission, distribution, and commercialization of electricity, as well as natural gas distribution. The company operates through six segments: Generation, Transmission, Trading, Distribution, Gas, and Investees. Its activities include power generation mainly from hydroelectric sources, operation and maintenance of transmission and distribution infrastructure, electricity sales to captive and free-market customers, and gas distribution in Minas Gerais. The company derives a majority of its revenue from the Distribution segment, which comprises the distribution and sale of electricity to captive customers, and the operation and maintenance of infrastructure and related services.